Our study not only explores the molecular mechanism by which HOTAIR regulates PPARα but also verifies the therapeutic effect of the combined application of the PPARα agonist fenofibrate and siRNA HOTAIR on glioma through in vivo animal experiments. The gene discussed is PPARA; the disease is central nervous system cancer.